test
potenti
parainfluenza
viru
base
vector
provid
protect
vaccinia
viru
vacv
infect
engin
express
secret
vacv
protein
two
import
antigen
neutral
intracellular
matur
imv
extracellular
envelop
eev
virion
respect
protect
mice
lethal
intranas
vacv
challeng
requir
intranas
immun
primeboost
protocol
correl
low
vacvinduc
patholog
respiratori
tract
antivacv
neutral
antibodi
mice
immun
show
diseas
symptom
follow
vacv
challeng
loss
weight
hunch
symptom
delay
less
sever
unimmun
control
mice
immun
express
alon
confer
least
protect
effect
immun
includ
vector
express
alon
combin
vector
elicit
protect
vacv
challeng
even
cell
deplet
case
mice
defect
b
cell
product
mice
protect
vacv
challeng
least
year
immun
vector
show
signific
level
antivacv
neutral
antibodi
result
demonstr
potenti
vector
provid
long
last
protect
complex
human
respiratori
pathogen
vacv
also
highlight
need
understand
mechan
gener
strong
immun
respons
poorli
immunogen
viral
protein
respiratori
tract
major
entri
site
mani
pathogen
virus
includ
influenza
viru
paramyxovirus
coronavirus
pox
virus
herp
virus
outcom
viral
infect
significantli
influenc
immun
respons
mucos
surfac
respiratori
tract
includ
recruit
innat
immun
cell
activ
cell
antibodi
respons
murphi
virgin
woodland
randal
intens
interest
develop
vaccin
strategi
viral
vector
promot
strong
long
last
protect
immun
respons
viral
respiratori
tract
pathogen
particularli
import
viral
infect
differ
anatom
region
respiratori
tract
sinc
mechan
control
immun
airway
compart
differ
significantli
woodland
randal
overal
goal
work
describ
determin
capac
viral
vector
base
parainfluenza
viru
elicit
protect
lethal
respiratori
tract
infect
vaccinia
viru
vacv
poxvirus
variola
viru
caus
agent
smallpox
highli
fatal
monkey
poxviru
vacv
establish
lethal
infect
respiratori
tract
eg
buller
palumbo
kaufman
et
al
live
attenu
form
vacv
current
use
unit
state
licens
smallpox
vaccin
number
concern
rais
due
risk
advers
effect
vaccin
eg
jacob
et
al
vacv
also
present
major
challeng
develop
altern
vaccin
approach
base
purifi
vacv
protein
heterolog
vector
express
vacv
antigen
moss
first
vacv
exist
two
major
infecti
form
extracellular
envelop
virion
eev
intracellular
matur
virion
imv
importantli
vacv
antigen
critic
neutral
two
form
differ
fogg
et
al
hooper
et
al
exampl
myristoyl
transmembran
protein
imv
form
import
target
imv
neutral
aldazcarrol
et
al
frank
et
al
wolff
et
al
membraneanchor
vacv
protein
extracellular
domain
contain
region
relat
complement
regulatori
protein
engelstad
et
al
antibodi
import
neutral
eev
form
aldazcarrol
et
al
bell
et
al
galmich
et
al
antibodi
neutral
imv
neutral
virolog
eev
thought
immun
antigen
form
necessari
maximum
protect
lustig
et
al
second
challeng
develop
vector
immun
poxvirus
vacv
highli
immunogen
individu
protein
antigen
poorli
immunogen
outsid
context
vacv
infect
vaccin
purifi
vacv
protein
dna
vaccin
encod
vacv
protein
requir
multipl
immun
protect
respons
eg
berhanu
et
al
fogg
et
al
hooper
et
al
hooper
et
al
final
vacv
antigen
import
control
infect
initi
respiratori
tract
versu
system
rout
intraven
intraperiton
differ
immun
mechan
protect
differ
rout
infect
complet
understood
belyakov
et
al
kaufman
et
al
given
import
develop
safe
potent
vaccin
approach
respiratori
tract
pathogen
develop
parainfluenza
viru
vaccin
vector
arimilli
et
al
capraro
et
al
park
alexandermil
previou
work
mous
ferret
model
system
shown
intranas
deliveri
induc
potent
antibodi
respons
clear
respiratori
tissu
day
pi
without
evid
system
infect
likewis
vector
express
model
antigen
elicit
strong
long
last
cell
respons
display
high
avid
phenotyp
gray
et
al
park
alexandermil
importantli
vaccin
ferret
mice
recombin
vector
result
overt
patholog
evid
diseas
symptom
desir
properti
rais
potenti
use
vector
vaccin
complex
human
pathogen
infect
respiratori
tract
test
hypothesi
vector
elicit
protect
immun
respiratori
tract
vacv
infect
engin
vector
express
solubl
form
vacv
antigen
vector
elicit
long
term
year
protect
mice
lethal
vacv
challeng
depend
b
cell
cell
result
highlight
potenti
vector
provid
protect
complex
highli
lethal
human
pathogen
variola
viru
also
rais
critic
issu
gener
strong
immun
airway
compart
poorli
immunogen
protein
found
vacv
open
read
frame
vacv
protein
modifi
pcr
lack
sequenc
code
transmembran
domain
encod
ctermin
ha
tag
detect
modifi
gene
individu
insert
hnl
junction
encod
infecti
cdna
clone
flank
transcript
signal
fig
virus
recov
cdna
clone
design
growth
analys
show
detect
differ
tissu
cultur
cell
compar
wt
express
stabl
multipl
passag
shown
shown
fig
western
blot
analysi
lysat
cell
infect
virus
show
hatag
express
consist
predict
size
kda
respect
aldazcarrol
et
al
similar
previou
data
vsvbase
vector
braxton
et
al
express
somewhat
higher
level
examin
extracellular
media
fig
right
panel
show
effici
timedepend
releas
contrast
retain
within
cell
similar
seen
case
control
cytoplasm
protein
thymidin
kinas
tk
express
vector
longer
exposur
show
low
level
extracellular
protein
consist
secret
protein
link
signal
peptid
shinoda
et
al
determin
vector
confer
protect
lethal
vacv
challeng
group
mice
immun
pb
control
im
rout
pfu
day
mice
given
booster
immun
pb
dose
either
im
rout
posit
control
mice
receiv
singl
subleth
dose
vacv
pfu
twenti
one
day
boost
mice
challeng
vacv
equival
mtd
administr
lethal
weight
monitor
daili
shown
fig
posit
control
mice
receiv
subleth
dose
vacv
protect
death
follow
vacv
challeng
vacv
control
group
contrast
mice
receiv
pb
one
prime
dose
vector
pb
singl
im
group
fig
succumb
infect
day
importantli
mice
receiv
prime
follow
boost
vector
inin
group
surviv
lethal
vacv
infect
although
mice
immun
succumb
lethal
vacv
challeng
show
sign
vacvinduc
diseas
evid
fig
show
chang
bodi
weight
percentag
initi
weight
challeng
control
mice
immun
subleth
dose
vacv
show
chang
overal
weight
vacv
control
contrast
anim
group
show
substanti
loss
weight
becam
evid
day
maxim
day
post
vacv
challeng
mice
receiv
pb
singl
dose
vector
im
anim
primeboost
im
rout
imim
group
lost
substanti
weight
either
die
remov
studi
loss
weight
reach
initi
valu
importantli
mice
given
prime
boost
vector
fig
open
triangl
also
lost
weight
weight
loss
delay
compar
pb
control
inin
anim
began
recov
weight
day
post
challeng
determin
abil
individu
vector
confer
protect
group
mice
given
primeboost
immun
pfu
alon
alon
combin
two
vector
mice
challeng
mtd
vacv
administr
lethal
weight
monitor
daili
shown
fig
vacvimmun
control
mice
close
triangl
surviv
vacv
challeng
pbstreat
mice
open
triangl
succumb
challeng
day
day
approxim
mice
given
combin
plu
vector
given
vector
alon
show
high
level
protect
death
mice
given
vector
alon
show
slightli
lower
level
protect
lethal
vacv
challeng
result
surviv
challeng
support
result
weight
loss
shown
fig
mice
given
either
combin
plu
lost
least
amount
weight
follow
lethal
vacv
challeng
result
indic
immun
vector
express
alon
confer
least
protect
effect
immun
includ
vector
express
alon
combin
determin
degre
patholog
follow
vacv
challeng
mice
immun
pb
neg
control
subleth
vacv
dose
posit
control
pfu
primeboost
protocol
describ
fig
day
post
boost
mice
challeng
vacv
equival
mtd
administr
nasal
tissu
olfactori
lobe
brain
analyz
day
post
challeng
stain
hematoxylin
eosin
control
mice
immun
subleth
dose
vacv
show
intact
nasal
epithelium
clear
nasal
caviti
fig
panel
b
contrast
pbstreat
mice
show
inflammatori
exud
panel
c
fill
much
nasal
caviti
bilater
extens
cribiform
plate
adjac
olfactori
lobe
white
arrow
panel
c
extens
destruct
nasal
epithelium
black
arrow
panel
inflammatori
cell
present
submucosa
nasal
caviti
mice
immun
vector
vacv
challeng
result
small
amount
exud
seen
nasal
caviti
extens
brain
region
fig
panel
e
higher
magnif
show
low
level
inflammatori
cell
exud
minim
disrupt
nasal
epithelium
panel
f
immun
anim
show
signific
lesion
lung
tissu
organ
includ
heart
liver
kidney
spleen
shown
togeth
data
indic
mice
immun
vector
show
rel
low
level
patholog
nasal
tissu
day
post
vacv
challeng
compar
control
anim
succumb
vacv
infect
determin
vacv
load
lung
tissu
follow
challeng
infect
group
mice
immun
describ
legend
fig
challeng
mtd
vacv
day
boost
day
post
challeng
titer
vacv
lung
tissu
determin
plaqu
assay
shown
fig
vacv
detect
tissu
control
mice
given
subleth
dose
vacv
consist
lack
diseas
symptom
anim
pbstreat
mice
high
vacv
titer
lung
tissu
day
succumb
infect
fig
denot
anim
surviv
importantli
mice
immun
vector
vacv
titer
lung
tissu
log
lower
seen
pb
treat
control
mice
day
day
challeng
detect
vacv
lung
mice
immun
vector
sampl
fig
given
kinet
weight
loss
vacv
challeng
mice
begin
day
reach
low
point
day
approach
normal
level
day
result
suggest
recoveri
diseas
symptom
protect
lethal
correl
clearanc
vacv
lung
tissu
protect
lethal
vacv
challeng
elicit
vector
requir
b
cell
cell
defin
mechan
protect
mediat
vector
group
mice
immun
describ
primeboost
protocol
pb
subleth
vacv
combin
vector
eighteen
day
boost
vector
cell
deplet
mice
consecut
day
daili
administr
monoclon
antibodi
detail
materi
method
flow
cytometr
analysi
show
treatment
result
decreas
cell
less
total
splenic
cell
data
shown
challeng
mtd
vacv
mice
monitor
lethal
diseas
symptom
shown
fig
pbstreat
control
mice
succumb
lethal
infect
day
close
triangl
wherea
mice
immun
vector
complet
protect
open
circl
control
mice
receiv
singl
subleth
dose
vacv
also
succumb
vacv
challeng
close
squar
find
consist
previou
report
role
cellular
immun
case
vacv
infect
belyakov
et
al
wyatt
et
al
although
immun
mice
protect
lethal
still
show
diseas
symptom
hunch
loss
weight
data
shown
mice
magnitud
weight
loss
kinet
weight
loss
maxim
day
post
challeng
similar
seen
without
deplet
data
shown
thu
protect
vacv
lethal
induc
depend
cell
determin
role
b
cell
protect
elicit
vector
jh
mice
lack
b
cell
immun
primeboost
protocol
describ
challeng
day
boost
mtd
vacv
lethal
diseas
symptom
monitor
daili
shown
fig
jh
mice
immun
vector
succumb
vacv
challeng
rate
slightli
delay
compar
seen
pbstreat
control
mice
contrast
control
mice
immun
subleth
dose
vacv
fulli
protect
jh
mice
immun
pb
vector
show
appear
diseas
symptom
loss
weight
hunch
day
day
post
vacv
challeng
data
shown
taken
togeth
data
indic
protect
vacv
challeng
elicit
vector
requir
b
cell
cell
assay
antibodi
respons
mice
immun
pfu
either
serum
collect
day
day
mice
boost
equival
amount
viru
serum
collect
day
post
boost
day
post
boost
mice
sacrif
bronchoalveolar
lavag
bal
fluid
collect
level
serum
igg
specif
determin
use
previous
describ
elisa
base
reactiv
purifi
particl
braxton
et
al
capraro
et
al
delaney
et
al
likewis
bal
fluid
test
elisa
antigenspecif
iga
igg
respons
shown
fig
vector
elicit
low
serum
igg
level
day
specif
open
triangl
close
squar
day
post
primari
immun
titer
slightli
increas
anim
fail
show
seroconvert
fig
day
post
boost
howev
nearli
anim
seroconvert
result
contrast
respons
elicit
subleth
vacv
infect
shown
previous
elisa
system
produc
titer
respect
braxton
et
al
similarli
vector
elicit
iga
igg
titer
bal
limit
detect
elisa
fig
low
bal
ig
titer
contrast
strong
iga
igg
titer
bal
fig
averag
respect
result
similar
publish
previous
show
vsv
vector
express
elicit
low
titer
two
vacv
protein
braxton
et
al
vacv
exist
two
major
infecti
form
extracellular
envelop
virion
eev
intracellular
matur
virion
imv
may
differ
requir
neutral
fogg
et
al
hooper
et
al
determin
vector
elicit
antibodi
capabl
neutral
imv
form
vacv
sera
anim
immun
combin
analyz
vitro
neutral
assay
pfu
imv
vacv
incub
dilut
serum
determin
remain
infect
plaqu
assay
shown
fig
sera
anim
immun
vector
contain
statist
signific
level
neutral
activ
estim
dilut
reduc
infect
noteworthi
assay
dilut
serum
vitro
may
give
bias
view
rel
undilut
natur
blood
contrast
sera
control
mice
immun
pb
show
signific
reduct
plaqu
fig
data
indic
elisa
show
low
antibodi
titer
anim
sera
capabl
neutral
vacv
function
assay
determin
vector
elicit
antibodi
also
capabl
neutral
eev
vacv
sera
anim
immun
combin
analyz
plaqu
reduct
assay
eev
form
vacv
shown
fig
sera
control
mice
immun
pb
control
vector
lack
foreign
gene
show
neutral
eev
vacv
wherea
sera
control
vacv
immun
mice
effect
neutral
importantli
sera
mice
immun
capabl
neutral
eev
form
vacv
slightli
lower
extent
compar
neutral
imv
form
shown
fig
thu
immun
vector
express
elicit
neutral
antibodi
capabl
inactiv
imv
eev
form
vacv
protect
vacv
elicit
mice
vector
long
last
demonstr
fig
mice
given
primeboost
immun
pb
control
combin
pfu
singl
subleth
dose
vacv
mice
hous
year
challeng
mtd
vacv
shown
fig
mice
immun
subleth
dose
vacv
vector
protect
lethal
challeng
one
age
mice
die
experi
due
necrosi
result
tail
bleed
star
fig
due
lack
protect
challeng
newli
immun
challeng
anim
mice
previous
immun
challeng
later
point
show
loss
weight
day
post
challeng
rapidli
regain
weight
nearli
initi
valu
fig
serum
mice
immun
vector
contain
statist
signific
level
neutral
antibodi
year
immun
evid
fig
dilut
serum
mice
immun
vector
reduc
imv
vacv
infect
compar
seen
control
sera
control
mice
receiv
subleth
vacv
infect
fig
taken
togeth
data
indic
vector
elicit
protect
lethal
vacv
challeng
requir
primeboost
combin
rout
seen
either
effect
vector
includ
reduc
vacv
induc
patholog
nasal
tissu
requir
b
cell
affect
deplet
cell
long
last
mice
least
year
immun
goal
work
describ
test
abil
vector
elicit
protect
immun
lethal
vacv
challeng
infect
rout
chosen
base
need
new
vaccin
protect
aerosol
vacv
may
differ
requir
protect
challeng
rout
kaufman
et
al
assumpt
parainfluenza
virus
would
elicit
robust
respons
infect
respiratori
rout
result
indic
vector
express
vacv
protein
confer
long
last
protect
immun
lethal
vacv
challeng
protect
vacvmedi
lethal
requir
prime
plu
boost
immun
protocol
administ
rout
depend
b
cell
cell
capabl
protect
mice
longer
year
immun
immun
vector
express
alon
confer
least
protect
effect
immun
involv
express
alon
combin
taken
togeth
result
support
develop
vector
immun
highli
pathogen
complex
human
virus
poxvirus
mice
respond
vector
gener
high
elisa
titer
antibodi
vector
rel
low
elisa
titer
antibodi
vacv
protein
previous
shown
wt
elicit
strong
antibodi
respons
detect
serum
includ
high
igg
iga
respons
bal
fig
contrast
result
elisa
data
show
serum
antibodi
respons
low
level
detect
bal
fig
consist
previou
work
show
protein
poorli
immunogen
express
outsid
context
nativ
vacv
also
reflect
need
multipl
vaccin
pure
protein
gener
high
antibodi
titer
provid
protect
berhanu
et
al
braxton
et
al
delaney
et
al
fogg
et
al
hooper
et
al
xiao
et
al
known
initi
innat
respons
mous
lung
infect
howev
shown
clear
respiratori
tract
day
infect
unlik
innat
respons
vector
contribut
substanti
protect
lethal
vacv
infect
support
key
find
protect
requir
b
cell
mice
protect
year
immun
vector
importantli
howev
vector
elicit
protect
mice
depend
b
cell
gener
function
antivacv
antibodi
titer
easili
detect
vitro
neutral
assay
fig
data
suggest
vector
elicit
memori
b
cell
respond
secondari
exposur
vacv
challeng
increas
level
neutral
antivacv
antibodi
altern
protect
vacv
challeng
could
involv
antibodymedi
cellular
cytotox
adcc
complementmedi
cell
lysi
depend
antibodi
vacv
protein
role
complement
vacv
protect
shown
previous
benhnia
et
al
current
test
context
vector
contrast
recent
work
vsvbase
vector
express
singl
immun
provid
protect
braxton
et
al
vectormedi
protect
lethal
vacv
infect
requir
prime
boost
immun
administ
rout
may
reflect
higher
level
prolong
express
antigen
airway
mice
infect
vsv
vector
compar
vector
view
find
antibodi
respons
primari
infect
mice
strong
titer
somewhat
surpris
boost
vector
promot
protect
vacv
challeng
particularli
true
titer
bal
high
iga
work
progress
defin
mechan
boost
vector
influenc
protect
vacv
challeng
even
face
strong
respons
due
prior
exposur
vector
clearli
protect
mice
succumb
lethal
vacv
infect
immun
anim
display
sign
ill
follow
vacv
challeng
notabl
mice
loss
weight
start
day
also
evid
sign
ill
hunch
ruffl
fur
conjunct
labor
breath
lethargi
unrespons
stimulu
shown
importantli
kinet
appear
ill
mice
delay
less
sever
compar
control
pbstreat
anim
anim
show
improv
near
normal
properti
day
post
challeng
similar
result
shown
anim
vaccin
purifi
vacv
protein
delaney
et
al
fogg
et
al
vsvbase
vector
express
braxton
et
al
immun
anim
lost
weight
follow
vacv
challeng
even
though
protect
lethal
diseas
symptom
anim
could
reflect
delay
respons
memori
b
cell
immun
anim
vacv
antigen
challeng
addit
possibl
includ
lower
immun
respons
vaccin
due
fact
immun
anim
expos
two
multipl
antigen
protein
express
vacv
infect
berhanu
et
al
fogg
et
al
hooper
et
al
altern
conform
express
versu
bone
fide
vacv
infect
latter
case
engin
express
solubl
version
enhanc
releas
infect
cell
possibl
uptak
secret
antigen
howev
immunogen
particularli
sensit
conform
chang
su
et
al
may
elicit
strong
antibodi
respons
due
express
hatag
cytoplasm
protein
intens
interest
develop
paramyxovirusbas
vector
vaccin
therapeut
applic
bukreyev
et
al
lamb
park
von
messl
cattaneo
vector
attract
properti
rel
vector
base
virus
associ
human
diseas
desir
properti
includ
infect
larg
noncytopath
cell
type
associ
diseas
human
goswami
et
al
ferret
mice
stimul
strong
antibodi
cell
respons
clear
respiratori
tissu
day
pi
without
evid
system
infect
induc
overt
patholog
discuss
previous
ferret
model
may
appropri
system
analysi
featur
vector
sinc
mous
good
predictor
viral
permiss
tropism
human
elicit
strong
system
mucos
igg
iga
respons
even
deliv
differ
rout
grown
high
titer
pfuml
vero
cell
approv
cell
line
vaccin
work
final
seropreval
rel
low
mani
human
popul
hsiung
johnson
et
al
vector
shown
elicit
protect
immun
mice
influenza
viru
tompkin
et
al
although
mechan
protect
studi
address
previou
report
associ
human
diseas
includ
multipl
sclerosi
goswami
et
al
time
attract
associ
larg
due
properti
readili
establish
persist
infect
cell
low
level
patholog
choppin
importantli
claim
disproven
mclean
thompson
current
thought
associ
human
diseas
variant
isol
sampl
human
patient
chatziandr
et
al
diverg
sequenc
isol
indic
common
lab
contamin
repres
bone
fide
human
infect
establish
persist
infect
mice
ferret
viral
load
appear
restrict
respiratori
tract
whether
establish
persist
infect
human
known
work
rais
import
question
virusbas
vector
could
improv
upon
order
gener
complet
protect
immun
differ
compart
respiratori
tract
reduc
diseas
symptom
previous
shown
engin
express
agonist
flagellin
enhanc
abil
stimul
human
dendrit
cell
cell
arimilli
et
al
likewis
shown
vector
base
rna
synthesi
mutant
potent
activ
innat
adapt
immun
manus
park
result
variant
support
gener
hypothesi
paramyxoviru
vector
design
express
target
antigen
along
immunomodulatori
factor
elicit
broader
respons
protect
lethal
well
reduc
diseas
symptom
gene
vacv
describ
previous
aldazcarrol
et
al
open
read
frame
modifi
pcr
encod
ctermin
ha
tag
insert
cdna
encod
intergen
region
hnl
junction
describ
previous
et
al
new
gene
flank
transcript
signal
deriv
npp
gene
junction
fulli
function
direct
transcript
foreign
gene
addit
transcript
unit
detail
clone
step
avail
request
recombin
virus
individu
express
recov
describ
previous
cdna
plasmid
kindli
provid
robert
lamb
northwestern
univers
biao
univers
georgia
tkexpress
describ
vivo
experi
virus
concentr
centrifug
glycerol
cushion
h
rpm
rotor
viru
pellet
resuspend
small
volum
dmem
contain
bsa
imv
form
western
reserv
wr
strain
vacv
prepar
purifi
describ
delaney
et
al
eev
form
vacv
prepar
exactli
describ
benhnia
et
al
store
prior
use
assay
neutral
assay
carri
describ
previous
briefli
pfu
vacv
treat
vari
concentr
immun
control
serum
h
sera
heat
inactiv
describ
previous
incub
viral
titer
determin
plaqu
assay
cell
result
averag
six
reaction
signific
data
point
calcul
use
student
ttest
research
perform
mice
studi
compli
feder
institut
guidelin
set
forth
wake
forest
univers
anim
care
use
committe
femal
balbc
mice
week
age
purchas
charl
river
jh
b
celldefici
mice
balbc
origin
mice
anesthet
avertin
immun
intranas
previous
describ
gray
et
al
pfu
purifi
vector
pb
control
anim
given
subleth
dose
median
toler
dose
mtd
vacv
pfu
administr
pb
wake
forest
univers
acuc
allow
death
endpoint
use
mtd
denot
dose
anim
show
sign
ill
eg
loss
weight
initi
signific
enough
warrant
euthanasia
thu
anim
toler
dose
viru
primeboost
protocol
mice
given
second
immun
pfu
viru
indic
day
post
primari
immun
challeng
experi
mice
anesthet
avertin
infect
pfu
vacv
pb
equival
time
mtd
mice
monitor
weigh
daili
assess
ill
mice
lose
greater
initi
weight
exhibit
sever
diseas
sign
indic
impend
death
euthan
requir
iacuc
guidelin
wake
forest
univers
health
scienc
indic
day
pi
mice
sacrif
lung
harvest
dissect
snapfrozen
store
tissu
homogen
use
powergen
tissu
homogen
fisher
scientif
follow
clarif
tissu
debri
g
min
describ
previous
use
plaqu
assay
describ
statist
weight
loss
surviv
calcul
student
test
logrank
respect
deplet
cell
carri
describ
previous
braxton
et
al
delaney
et
al
briefli
purifi
antibodi
clone
hybridoma
cell
grown
confluenc
cell
pellet
centrifug
media
filter
concentr
concentr
media
dialyz
mm
sodium
phosphat
bind
buffer
antibodi
purifi
use
akta
chromatographi
system
follow
elut
mm
glycin
elut
buffer
solut
antibodi
dialyz
pb
concentr
determin
bca
deplet
cell
mice
inject
intraperiton
consecut
day
mg
antibodi
total
volum
ml
pb
control
mice
receiv
intraperiton
inject
pb
deplet
confirm
flow
cytometri
deplet
result
loss
cell
cell
total
splenic
cell
indic
day
pi
mice
bled
tail
vein
blood
allow
clot
overnight
clarif
centrifug
elisa
carri
describ
previous
antibodi
braxton
et
al
delaney
et
al
protein
use
elisa
baculovirusderiv
recombin
histidinetag
protein
gener
cultur
cell
purifi
metal
affin
resin
describ
previous
delaney
et
al
western
blot
dish
cell
infect
describ
figur
legend
time
point
media
collect
concentr
tca
precipit
resuspend
sd
cell
wash
pb
lyse
sd
protein
concentr
determin
bca
assay
pierc
chemic
timepoint
entir
media
sampl
cell
lysat
analyz
gel
electrophoresi
reduc
condit
typic
recoveri
cell
lysat
protein
thu
protein
analyz
repres
total
intracellular
sampl
western
blot
carri
rabbit
antiserum
specif
np
protein
rat
monoclon
antibodi
specif
ha
tag
contain
protein
roch
inc
blot
visual
horseradish
peroxidaseconjug
secondari
antibodi
enhanc
chemiluminesc
pierc
chemic
head
mice
remov
preserv
whole
neutral
buffer
formalin
least
h
decalcifi
polysci
h
cross
section
made
nose
level
olfactori
lobe
brain
tissu
return
formalin
embed
paraffin
process
routin
histolog
cut
stain
hematoxylin
eosin
h
e
section
examin
board
certifi
veterinari
pathologist
repres
two
experi
